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and rigors, generalized and throbbing headache, and 
repeated episodes of projectile vomiting, one week of 
abnormal behavior, focal seizures and weakness of 
the left limbs and, five days later of loss of 
consciousness. There was no photophobia, neck 
stiffness, night sweats, weight loss or contact with a 
TB case, although she ingested unpasteurized fresh 
cow milk. She had no history of diabetics, 
hypertension, sickle cell disease, high risk sexual 
behavior, or illicit drug use, alcohol consumption or 
cigarette smoking and no recent travel outside 
Nigeria. On presentation, she was toxic looking, 
0 febrile (39.4 C), diaphoretic, dehydrated, moderately 
pale, anicteric with no significant lymphadenopathy. 
Glasgow coma scale (GCS) was 6/15. There were no 
signs of meningeal irritations and pupils were normal 
in size and reacted briskly to bright pen torch light. 
The eyes roved spontaneously and conjugately. There 
were bilateral papilloedema on fundoscopy; left 
supranuclear facial nerve palsy and an ipsilateral 
spastic hemiplegia. Other systems were normal. A 
provisional diagnosis of tuberculous encephalitis 
with right hemispheric tuberculomas was made, with 
a differential diagnosis of brucella encephalitis and? 
toxoplasmosis. 
Brain T1 weighted MRI done on admission showed 
multiple hyper intense lesions in the thalami (the 
right being more affected than the left), the left basal 
ganglia and cerebral cortex, with periventricular 
oedema and mild communicating hydrocephalus. 
There was no ring enhancing lesion seen (Figure 1). 
INTRODUCTION 
1Brucellosis , also called Malta fever /Mediterranean 
f e v e r /  G i b r a l t a r  f e v e r / C y p r u s  f e v e r  
/remittent/undulant fever from the intermittent 
nature of the fever, is a zoonotic disease transmitted 
to humans through ingestion of untreated milk, milk 
products or by contact with infected animals, animal 
discharges (urine, stool, vaginal and products of 
conception), meat or bone marrow through the skin, 
conjunctiva or lungs. Rarely transmission has 
occurred via sex or to babies via placenta or breast 
2milk . Human disease can be caused by  any of four 
3species ;-Brucella melitensis  acquired primarily 
from goats, sheep and camels; Brucella abortus from 
cattle; Brucella suis from pigs/hogs; and Brucella 
canis from dogs.
These organisms migrate to the regional lymph 
nodes, thence by hematogenous spread to other 
organs including the nervous system.  It is difficult to 
know how frequently the nervous system is affected, 
because of nonspecificity of the infection, difficulties 
in diagnosis and variability in reporting such 
4complications .  As there is no known report of this 
condition from the African continent, we decided, 
therefore, to report this case diagnosed in our centre 
through brain magnetic resonance imagining (MRI) 
and brucella antigen agglutination test.
CASE REPORT
N.D, a 28 year old spinster was referred to us from 
thJos on the 6  of June 2007 with a month history of left 
hip pain, high grade, intermittent fever with chills 
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ABSTRACT
Neurobrucellosis is a rare form of systemic brucellosis, a disease acquired through ingestion of unpasteurized 
dairy products, which may manifest as stroke, encephalitis, meningitis, or psychiatric disorders. Presently 
there is no known report of neurobrucellosis in Nigeria, although consumption of unpasteurized dairy products 
is not uncommon in this country. In this report we present a 28 year old spinster with history of significant 
ingestion of unpasteurized cow milk and brucellosis of the brain diagnosed in our centre through brain 
magnetic resonance imagining (MRI) and brucella antigen agglutination test. Because of the indolent nature of 
brucellosis infection, it should be suspected in individuals with pyrexia of unknown origin so that early 
detection and treatment could prevent long-term sequelae such as focal neurologic deficits, hydrocephalus and 
psychiatric illness. 
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Three cultured blood specimens yielded no growth.  
Urine and stool cultures also yielded no growth. 
Packed cell volume was 27%, with total white blood 
count of 6.8X109/L, (made up of 84% neutrophils 
and 16% lymphocytes) .The erythrocyte  
sedimentation 
Figure 1:T1 Weighted MRI of Brain showing 
Hyper-intense lesions in the thalami (right > left), 
right basal ganglia and cerebral cortex.
rate (ESR) was 10mm/hour, Mantoux 
skin reaction was negative, and HIV- 1& 2 were sero-
negative. Serum urea, uric acid, electrolytes, 
creatinine, calcium, phosphate and proteins were all 
within normal limits. Random blood sugar was 
5.6mmol/l. Liver transaminases [aspartate 
transaminase of 90 i.u/L (normal range 5-22), alanine 
transaminase of 102IU/L (normal range 16-40)] were 
raised, while alkaline phosphatase and total bilirubin 
l e v e l s  w e r e  n o r m a l .  C h e s t  x - r a y s ,  
electrocardiography and echocardiography were 
essentially normal. Brucella abortus agglutinin test 
yielded a titre of 1:128. These investigation results 
pointed more towards neurobrucellosis than 
tuberculosis, and so anti-brucellosis therapy was 
instituted with intramuscular (IM) Streptomycin 1g 
daily, caps Rifampicin 600 mg daily and 
Doxycycline 100 mg b.d through a naso-gastric tube, 
which also served for feeding.  She was also put on 
IV dexamethasone 8mg 6hourly, IV normal saline 3-
6 litres/day. Seizures were controlled with Phenytoin 
300 mg daily P.O., and two tablets of 
artesunate/amodiaquine daily were given for 3 days 
(after a result of +1 plasmodium falciparum 
parasitemia was received). Four weeks later, pyrexia 
began to subside with more apyrexic intervals, GCS 
improved to 10/15 but focal deficits persisted. 
Repeat brain T1 weighted MRI revealed resolution of 
previous hyper intense lesions in the thalami, basal 
ganglia and cerebral cortex, but the size of the 
communicating hydrocephalus increased (figure 2). 
Repeat brucella antigen agglutination test yielded a 
titre of 1:64. 
The patient was continued on Doxycycline 100 mg 
b.d PO, Rifampicin 600 mg PO and Streptomycin 1g 
IM . Dexamethasone was stopped. She had regular 
physiotherapy and adequate skin, bladder and bowel 
thcare. At the 8  weeks, her clinical condition remained 
stable, fever stopped, but GCS and focal deficits 
remained unchanged. Repeat brucella antigen 
agglutination test yielded a titre of 1:16.She was 
subsequently transferred to a neurosurgical facility 
because of worsening hydrocephalus. 
Figure 2: T1 Weighted MRI of Brain showing 
resolution of previous hyper-intense lesions and 
severe communicating hydrocephalus.
DISCUSSION
The global incidence of human brucellosis is not 
known because of the variable quality of disease 
reporting and notification system in many countries. 
As a result, it is usually underreported, although over 
500,000 cases are reported yearly from 100 
4countries . Even in   Europe and United States of 
America with stringent disease surveillance and 
report systems, the true incidence of this disease is 
5, 6not known , although some countries in Europe are 
6reported to be free of brucellosis . In Nigeria with a 
significant population of herdsmen, no literature on 
this condition is available to these authors. 
Neurobrucellosis is uncommon, developing in <5% 
. of patients with Brucella infection , and producing 
7diverse neurological syndromes , even in the same 
 8patient , the most frequent  being diffused or 
9 10localized meningitis or meningoencephalitis  
which could be acute, subacute, relapsing or chronic. 
Less than 50% of patients may exhibit meningeal 
signs. Clinical features may include alteration of 
consciousness, psychiatric disturbances, long tract 
signs, convulsions and focal neurologic deficits 
especially in the presence of multiple cerebral 
lesions.   Involvement of cranial nerves II, III, IV and 
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VI in basal meningitis may lead to papillitis, 
papilloedema, retrobulbar neuritis, optic atrophy and 
opthalmoplegia.  These features may be 
indistinguishable from those of tuberculous or fungal 
11,12meningitis and CSF findings are similar . It is 
therefore not surprising that a diagnosis of 
tuberculosis was considered first in our patient as 
tuberculosis is commoner in our environment than 
12brucellosis. The infection  may also produce 
subarachnoid hemorrhages from ruptured mycotic 
aneurysm; embolic stroke from emboli from brucella 
endocarditis. Thrombotic strokes can be caused by 
vasculitic changes in the cerebral vessels and this 
phenomenon must be responsible for the residual 
neurological deficit seen in this patient.  
Mass lesions within the brain parenchyma are 
extremely uncommon but have been documented 
 13radiologically and pathologically . Lower thoracic 
and lumbar myelopathy, acute and chronic may result 
from several different mechanisms such as acute 
transverse myelitis, spinal cord infarction, adhesive 
arachnoiditis, and compression from epidural 
abscess, brucella spondylitis, and/or vertebral 
erosion and collapse.    Diagnostic confusion may 
occur with lumbar disc protrusion and tuberculous 
spondylitis. Cervico-brachial plexopathies, lumbo-
sacral plexo-radiculopathies may occur as part of 
inflammatory processes. Mononeuritis multiplex 
7and peripheral neuropathies have been described .   
Brucellosis as a cause of psychiatric illness is easily 
missed especially if the patient has no overt physical 
12abnormality . All this diverse manifestations can 
lead to confusion and delay in diagnosis and may lead 
to diffulties in differentiating this condition from 
other chronic infections like tuberculosis and 
15syphilis .
Antibody against brucella may be demonstrated in 
serum and cerebrospinal fluid (CSF) by enzyme 
linked immuno-sorbant assay (ELISA), standard 
tube agglutination (SAT), the 2-mercaptoethanol 
agglutination test and Coombs' test  using Brucella 
abortus antigens, which cross- react with Brucella 
melitensis and Brucella suis but not with Brucella 
canis (which has no approved commercial kits).  No 
single titre of brucella antibodies is diagnostic. 
However, in endemic areas, a titre of 1:320 or 1:640 
is significant while a titre above 1:80 in non endemic 
areas is considered significant in serum or CSF; 
although CSF titres are lower than those of the serum. 
In endemic areas, a high titre in the absence of 
symptoms should be followed by re-evaluation in 2-4 
14weeks and a further rise in titre sought . 
Cultures of blood and bone marrow are positive in 
50-70% of cases, but could last up to 6 weeks before 
growth of organism is seen. Subcultures could be 
prepared on special media or duplicate blood agar 
plates (with or without 10% carbon dioxide). 
Radiological abnormalities are nonspecific and 
computerized tomographic (CT) appearances of 
neurobrucellosis are similar to those of tuberculosis 
a n d  o t h e r  g r a n u l o m a t o u s  
meningitides/encephalitides. However, MRI is 
modality of choice as it shows diffuse hyper intense 
signals in affected nuclei.
The major problem in antibiotic treatment is the 
15intracellular location of the organism . There is no 
unanimity of opinion regarding the optimal regimen. 
Most authorities recommend the use of doxycycline 
100 mg PO BID in combination with two or more 
other drugs ( Rifampicin 600-900 mg PO QD/ 
streptomycin 1 g IM QD  or trimethoprim- 
sulfamethoxazole 960 mg ) for one to nine months till  
serum /CSF antibody titres are reduced to a 
minimum. Other regimens include: Netilmicin 2 
mg/kg 12 hourly IM or Gentamicin 3-5 mg/kg /day in 
divided doses 8 hourly plus Doxycycline 100 mg 
BID. Benefits of corticosteroids have not been 
demonstrated in clinical trials. Mortality is low and 
the cause of death may not always be related to 
15brucellosis . All patients should be kept under 
review for at least a year following completion of 
antibiotic course when the serum agglutinins should 
have fallen to normal level. Because of the indolent 
nature of this infection, early detection and treatment 
could prevent long-term neurologic complications of 
chronic intracranial inflammatory process such as 
hydrocephalus as occurred in our patient. 
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